2015
DOI: 10.3171/2015.3.peds1525
|View full text |Cite
|
Sign up to set email alerts
|

Embryonal tumor with multilayered rosettes of the fourth ventricle: case report

Abstract: Embryonal tumor with multilayered rosettes (ETMR) is a recently described pathological entity. These primitive central nervous system tumors harbor amplification of the 19q13.42 locus and resultant overexpression of the LIN28A protein. Although the WHO currently recognizes 3 distinct histopathological entities—embryonal tumor with abundant neuropil and true rosettes (ETANTR), ependymoblastoma, and medulloepithelioma—recent studies indicate that these tumors have a common molecular profile and clinical … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
5
0

Year Published

2017
2017
2023
2023

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 9 publications
(5 citation statements)
references
References 31 publications
0
5
0
Order By: Relevance
“…Other authors have reviewed cases of MEP and EPL described since the 1920s to 1990 [45] , [49] , [50] , [51] . The patient characteristics, treatment, and outcome of these 204 cases plus the seven MD Anderson cases are summarized in Table 3 [1] , [5] , [7] , [9] , [14] , [49] , [50] , [51] , [52] , [53] , [54] , [55] , [56] , [57] , [58] , [59] , [60] , [61] , [62] , [63] , [64] , [65] , [66] , [67] , [68] , [69] , [70] , [71] , [72] , [73] , [74] , [75] , [76] , [77] , [78] , [79] , [80] , [81] , [82] , [83] , [84] , [85] , [86] , [87] , [88] , [89] , [90] , [91] , [92] , [93] , [94] , [95] , [96] , [97] , [98] .…”
Section: Resultsmentioning
confidence: 99%
“…Other authors have reviewed cases of MEP and EPL described since the 1920s to 1990 [45] , [49] , [50] , [51] . The patient characteristics, treatment, and outcome of these 204 cases plus the seven MD Anderson cases are summarized in Table 3 [1] , [5] , [7] , [9] , [14] , [49] , [50] , [51] , [52] , [53] , [54] , [55] , [56] , [57] , [58] , [59] , [60] , [61] , [62] , [63] , [64] , [65] , [66] , [67] , [68] , [69] , [70] , [71] , [72] , [73] , [74] , [75] , [76] , [77] , [78] , [79] , [80] , [81] , [82] , [83] , [84] , [85] , [86] , [87] , [88] , [89] , [90] , [91] , [92] , [93] , [94] , [95] , [96] , [97] , [98] .…”
Section: Resultsmentioning
confidence: 99%
“…These tumors share a common molecular signature, C19MC alteration . Fewer than 100 cases of ETMR have been reported …”
Section: Introductionmentioning
confidence: 99%
“…Human ETMR is an aggressive, WHO-grade IV tumor that occurs predominantly in infants under the age of 3 years ( 4 ). Nearly all tumors reside in the brain, ~70% occurring in supratentorial and 30% in infratentorial regions ( 12 , 23 ) with reports of ETMRs occurring in the fourth ventricle ( 32 ). Human ETMRs mostly present as large well-demarcated tumors.…”
Section: Discussionmentioning
confidence: 99%